!
!
Sign in / Join ICS
Home
Evaluation of Combination Therapy (75 mg/day Naftopidil plus 30 mg/day Urapidil) in Patients with BPH/LUTS Poorly Responding to alpha1 Blocker Monotherapy
Matsuo T
1
, Miyata Y
1
, Watanabe S
1
, Sagara Y
1
, Ohba K
1
, Sakai H
1
Abstract Category
Benign Prostatic Hyperplasia (BPH)
Abstract 641
Read by Title
Scientific Non Discussion Abstract Session 31
1.
Department of Urology, Nagasaki University School of Medicine
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
21/08/2024 07:28:02